Publications

5674 Results

Cooperative group trials - Southwest Oncology Group (SWOG) innovations in advanced prostate cancer [PMID21085622; PMC2981166]

Authors
TB Dorff;C Tangen;ED Crawford;DP Petrylak;CS Higano;D Raghavan;DI Quinn;NJ Vogelzang;IM Thompson;MHA Hussain
Journal / Conference
Therapeutic Advances in Medical Oncology 1(2):69-77;
Year
2009
Research Committee(s)
Genitourinary
Study Number(s)
S0032, S0111, S0354, S0418, S0421, SWOG-8219, SWOG-8494 (INT-0036), SWOG-8894 (INT-0105) (EST-2889), SWOG-9346, SWOG-9407, SWOG-9426, S9916

Variants in the BRCA1/Fanconi-Anemia repair pathway and taxane-induced neuropathy in SWOG directed intergroup study S0221

Authors
LE Sucheston;H Zhao;S Yao;W Barlow;DL Hershman;GT Budd;W Davis;G Ciupak;J Stewart;C Isaacs;T Hobday;J Latreille;G Hortobagyi;J Gralow;R Livingston;K Albain;DF Hayes;CB Ambrosone
Journal / Conference
San Antonio Breast Cancer Symposium, 2009, poster presentation, abst. #2001
Year
2009
Research Committee(s)
Breast
Study Number(s)
S0221

Cetuximab (C225) plus cisplatin (CDDP), irinotecan (CPT11) and thoracic radiotherapy (TRT as definitive treatment for locally advanced, clinically unresectable esophageal cancer (EC): a Southwest Oncology Group (SWOG) phase II trial with molecular correlates (S0414)

Authors
CR Thomas;B Goldman;J Benedetti;HJ Lenz;T Baker;L Hammond-Thelin;VK Mehta;C Fenoglio-Preiser;J Abbruzzese;CD Blanke
Journal / Conference
International Journal of Radiation Oncology, Biology & Physics 75(3)supl., abst #1094, S168. ASTRO poster discuss.
Year
2009
Research Committee(s)
Gastrointestinal
Study Number(s)
S0414

SWOG 0222: a phase II study of tirapazamine/cisplatin/etoposide and concurrent thoracic radiotherapy for limited stage small cell lung cancer [PMC2702233; PMID19364954]

Authors
QT Le;J Moon;M Redman;SK Williamson;PN Lara;Z Goldberg;LE Gaspar;JJ Crowley;D Moore, Jr;DR Gandara
Journal / Conference
Journal of Clinical Oncology 27(18):3014-3019
Year
2009
Research Committee(s)
Lung
Study Number(s)
S0222

Genetic polymorphisms of EPHX1, Gsk3B, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma

Authors
B Durie;B Van Ness;C Ramos;O Stephens;M Haznadar;A Hoering;J Haessler;M Katz;G Mundy;R Kyle;GA Morgan;J Crowley;B Barlogie;J Shaughnessy
Journal / Conference
Leukemia 23(10):1913-1919
Year
2009
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9321

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systemic review and meta-analysis of prospective clinical trials [PMID9509382;PMC3163846]

Authors
J Koreth;R Schlenk;KJ Kopecky;S Honda;J Sierra;B Djulbegovic;M Wadleigh;DJ DeAngelo;RM Stone;H Sakamaki;FR Appelbaum;H Dohner;JH Antin;RJ Soiffer;C Cutler
Journal / Conference
Journal of the American Medical Association 301(22)2349-2361
Year
2009
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8124/25/26

Gene expression profiling of phenotypically-defined hormone-receptor positive breast cancer: evidence for increased transcriptional activity of the insulin growth factor receptor pathway and other pathways

Authors
J Sparano;RG Gray;LJ Goldstein;BH Childs;D Brassard;R Bugarini;S Rowley;J Baker;S Shak;S Badve;FL Baehner;P Kenny;E Perez;LN Shulman;S Martino;G Sledge;NE Davidson
Journal / Conference
San Antonio Breast Cancer Symposium, abstract #5165, poster presentation
Year
2009
Research Committee(s)
Breast
Study Number(s)
E2197

Black race is associated with a worse outcome in patients with hormone receptor positive, HER2-normal breast cancer treated with adjuvant chemohormonal therapy

Authors
J Sparano;M Wang;V Stearns;S Martino;V Jones;E Perez;T Saphner;A Wolff;G Sledge;W Wood;NE Davidson
Journal / Conference
San Antonio Breast Cancer Symposium, abstract #37 (general session)
Year
2009
Research Committee(s)
Breast
Study Number(s)
E1199

US intergroup anal carcinoma trial: tumor diameter predicts for colostomy [PMID19138424; PMC2667813]

Authors
JA Ajani;KA Winter;LL Gunderson;J Pederson;AB Benson;CR Thomas;RJ Mayer;MG Haddock;TA Rich;CG Willett
Journal / Conference
Journal of Clinical Oncology 27(7):1116-1121
Year
2009
Research Committee(s)
Gastrointestinal
Study Number(s)
R9811

Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on Selenium and Vitamin E Cancer Prevention Trial. PMID: 19528369

Authors
EA Platz;SM Lippman
Journal / Conference
Journal of Clinical Oncology 27(22):3569-3572
Year
2009
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000